Sroll To Bottom
Latest news
26
Jan

2026

Reasons to be Cheerful in 2026
03
Nov

2025

AAVantgarde Closes $141 Million Series B for Stargardt Disease and Usher 1B Syndrome clinical development
31
Oct

2025

Rafiq Hasan discusses Complement Tx’s FDA IND clearance to advance CTx001 into Opti-GAIN Phase I/II Trial in GA secondary to AMD on BiotechTV

Our services are thoughtfully crafted and constantly evolving to help achieve your goals

See us at...
We will be attending
28
Jan
Festival of Genomics, London
28-29 January 2026
11
Feb
Tech Arena, Stockholm
11-17 February 2026
17
Mar
Advanced Therapies, London
17-18 March 2026
Testimonials